PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: confidence

Johns Hopkins Health System and Office of Injection and ...

Johns Hopkins Health System and Office of Injection and Infusion Services Johns Hopkins Physicians Coding Policy Number: OUT001 Effective Date: 07/01/2019 I. INTRODUCTION The purpose of this coding guidance is to provide assistance and direction with coding determinations for the Johns Hopkins Health System (JHHS) and Office of Johns Hopkins Physicians (OJHP). These notifications are to be made available to all staff members involved in the coding and reporting of infusion and Injection services. This recommendation has been vetted and approved. The certified coding professional should refer to the applicable Official ICD-10-CM Guidelines for Coding and Reporting as well as follow all instructions in the coding manuals, as the notification may not be all inclusive. The Centers for Medicare & Medicaid Services (CMS) considers Coding Clinic, published by the American Hospital Association (AHA), as an official source for coding guidelines for ICD-10 and PCS.

Note: The administration of an antineoplastic drug, non-radionuclide anti-neoplastic drug, anti-neoplastic agent or certain monoclonal antibodies is coded as a chemotherapy infusion procedure. See approved list of non-chemotherapeutic drugs in the attached APPENDIX A.

Tags:

  Lists, Anti, Antineoplastic, Neoplastic, Anti neoplastic

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of Johns Hopkins Health System and Office of Injection and ...

Related search queries